Guzick D S
Am J Public Health. 1978 Feb;68(2):125-34. doi: 10.2105/ajph.68.2.125.
Cytologic screening for cervical cancer currently enjoys wide acceptance, but there remains controversy in the literature concerning its efficacy in prolonging life. On the basis of a literature review, several conclusions are reached: 1) Cervical screening can identify women who are at greater-than-average risk of developing invasive cervical cancer by detecting asymptomatic lesions that would frequently progress to invasion if left untreated; 2) Therapy based on confirmed positive smears can reduce the incidence and mortality rates of invasive cervical cancer, as shown by declining rates in many centers that had constant or increasing rates before screening began, lower rates for geographic areas and occupational groups having less screening, and lower rates among screened women than unscreened women; and 3) Attempts to estimate the amount of life prolongation attributable to cervical screening have not yet yielded reliable figures, because of difficulties with the models or data used. However, in view of the available evidence, it is suggested that incomplete data should not prevent a vigorous continuation of screening where it is already extensive, and an escalation where it is not.
目前,宫颈癌的细胞学筛查已被广泛接受,但关于其延长生命功效的文献仍存在争议。基于文献综述,得出以下几个结论:1)宫颈筛查可以通过检测无症状病变来识别患浸润性宫颈癌风险高于平均水平的女性,如果不治疗,这些病变通常会发展为浸润;2)基于确诊阳性涂片的治疗可以降低浸润性宫颈癌的发病率和死亡率,许多中心在开始筛查前发病率持续或上升,而筛查后发病率下降,筛查较少的地理区域和职业群体发病率较低,且筛查女性的发病率低于未筛查女性,这些都表明了这一点;3)由于所使用的模型或数据存在困难,试图估计宫颈筛查可延长的寿命尚未得出可靠数字。然而,鉴于现有证据,建议在筛查已经广泛开展的地方,不完整的数据不应妨碍大力继续筛查;在筛查尚未广泛开展的地方,则应扩大筛查范围。